Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: A histopathological study

European Journal of Pharmaceutical Sciences

Volumn 59, Issue 1, 2014, Pages 20-30

  Zlatković, Jelena ^a   Todorović, Nevena ^a   Tomanović, Nada ^b   Bošković, Maja ^a   Djordjević, Snežana ^c   Lazarević Pašti, Tamara ^a   Bernardi, Rick E ^d   Djurdjević, Aleksandra ^e   Filipović, Dragana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e Medicines and Medical Devices Agency of Serbia   (Serbia)

Author keywords

Clozapine; Fluoxetine; Histopathology; Oxidative stress; Rat liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBONYL DERIVATIVE; CLOZAPINE; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; FLUOXETINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER ENZYME; MALONALDEHYDE; NITRIC OXIDE; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PTGS2 PROTEIN, RAT; SUPEROXIDE DISMUTASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER; LIVER INJURY; LIVER TOXICITY; MALE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SOCIAL ISOLATION; ANIMAL; BLOOD; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; METABOLISM; PATHOLOGY; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ASPARTATE AMINOTRANSFERASES; CLOZAPINE; CYCLOOXYGENASE 2; DRUG-INDUCED LIVER INJURY; FLUOXETINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LIVER; MALE; MALONDIALDEHYDE; NF-KAPPA B; NITRIC OXIDE; OXIDATIVE STRESS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84899794641     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.04.010     Document Type: Article

References (92)

1. D.H. Adams, C. Ju, S.K. Ramaiah, J. Uetrecht, and H. Jaeschke Mechanisms of immune-mediated liver injury Toxicol. Sci. 115 2010 307 321
2. P.W. Albro, J.T. Corbett, and J.L. Schroeder Application of the thiobarbiturate assay to the measurement of lipid peroxidation products in microsomes J. Biochem. Biophys. Methods 13 1986 185 194
3. V.E. Barakauskas, A.R. Ypsilanti, A.M. Barr, S.M. Innis, W.G. Honer, and C.L. Beasley Effects of sub-chronic clozapine and haloperidol administration on brain lipid levels Prog. Neuropsychopharmacol. Biol. Psychiatry 34 2010 669 673
4. A.P. Bautista, and J.J. Spitzer Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin Am. J. Physiol. 259 1990 907 912
5. K. Begriche, J. Massart, M.A. Robin, A. Borgne-Sanchez, and B. Fromenty Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver J. Hepatol. 54 2011 773 794
6. R.A. Bendele, E.R. Adams, W.P. Hoffman, C.L. Gries, and D.M. Morton Carcinogenicity studies of fluoxetine hydrochloride in rats and mice Cancer Res. 52 1992 6931 6935
7. A. Berson, V. De Boco, P. Letteron, M.A. Robin, C. Moreau, J. El Kahwaji, N. Verthier, G. Feldmann, B. Fromenty, and D. Pessayre Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 1998 764 774
8. N.L.R. Bucher, and R.A. Malt Regeneration of Liver and Kidney first ed. 1971 Little Brown, Boston
9. F.P. Bymaster, D.O. Calligaro, J.F. Falcone, F.D. Marsh, N.A. Moore, N.C. Tye, P. Seeman, and D.T. Wong Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 1996 87 96
10. A. Castiella, and J. Arenas Fluoxetine hepatotoxicity Am. J. Gastroenterol. 89 1994 458 459
11. K. Chan, D. Truong, N. Shangari, and P.J. O'Brien Drug-induced mitochondrial toxicity Expert. Opin. Drug. Metab. Toxicol. 1 2005 655 669
12. N.K. Cortas, and N.W. Wakid Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method Clin. Chem. 36 1990 1440 1443
13. L.V. Crowley The Reitman Frankel colorimetric transaminase procedure in suspected myocardial infarction Clin. Chem. 13 1967 482 487
14. B. Czeh, M. Simon, M.G. van der Hart, B. Schmelting, M.B. Hesselink, and E. Fuchs Chronic stress decreases the number of parvalbumin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist Neuropsychopharmacology 30 2005 67 79
15. B. Czéh, J.I. Müller-Keuker, R. Rygula, N. Abumaria, C. Hiemke, E. Domenici, and E. Fuchs Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment Neuropsychopharmacology 32 2007 1490 1503
16. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo Protein carbonyl groups as biomarkers of oxidative stress Clin. Chim. Acta 329 2003 23 38
17. P. Devbhuti, A. Saha, and C. Sengupta Gentamicin induced lipid peroxidation and its control with ascorbic acid Acta Pol. Pharm. 66 2009 363 369
18. A. Dhir, and S.K. Kulkarni Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor Eur. J. Pharmacol. 568 2007 177 185
19. S. Djordjevic, I. Kovacevic, B. Miljkovic, J. Vuksanovic, and M. Pokrajac Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: application to clinical study Farmaco 60 2005 345 349
20. J. Djordjevic, A. Djordjevic, M. Adzic, A. Niciforovic, and M.B. Radojicic Chronic stress differentially affects antioxidant enzymes and modifies the acute stress response in liver of Wistar rats Physiol. Res. 59 2010 729 736
21. G. Dorta, R. Siebenmann, P. Fröhli, P. Freytag, and H.R. Koelz Clozapine-induced cholestatic jaundice: a case report Z. Gastroenterol. 27 1989 388 390
22. S.C. Dulawa, K.A. Holick, B. Gundersen, and R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330
23. G. Dumortier, W. Cabaret, L. Stamatiadis, G. Saba, R. Benadhira, J.F. Rocamora, B. Aubriot-Delmas, J. Glikman, and D. Januel Hepatic tolerance of atypical antipsychotic drugs Encephale 28 2002 542 551
24. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
25. J.P. Feighner Mechanism of action of antidepressant medications J. Clin. Psychiatry 60 1999 4 11
26. M. Feldman, L.S. Friedman, and L.J. Brandt Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology, Diagnosis, Management eighth ed. 2006 Saunders Elsevier Philadelphia
27. J. Ferno, A.O. Vik-Mo, G. Jassim, B. Håvik, K. Berge, S. Skrede, O.A. Gudbrandsen, J. Waage, N. Lunder, S. Mørk, R.K. Berge, H.A. Jørgensen, and V.M. Steen Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver Psychopharmacology 203 2009 73 84
28. D. Filipović, L.M. Mandić, D. Kanazir, and S.B. Pajović Acute and/or chronic stress models modulate CuZnSOD and MnSOD protein expression in rat liver Mol. Cell. Biochem. 338 2010 167 174
29. E. Fuchs, and G. Flugge Experimental animal models for the simulation of depression and anxiety Dialogues Clin. Neurosci. 8 2006 323 333
30. I. Gaertner, K. Altendorf, A. Batra, and H.J. Gaertner Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7263 treatment courses J. Clin. Psychpharmacol. 21 2001 215 222
31. S. Gupta, R. Pandey, R. Katyal, H.K. Aggarwal, R.P. Aggarwal, and S.K. Aggarwal Lipid peroxide levels and antioxidant status in alcoholic liver disease Indian J. Clin. Biochem. 20 2005 67 71
32. E. Ha, K.H. Jung, B.K. Choe, J.H. Bae, D.H. Shin, S.V. Yim, and H.H. Baik Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells Neurosci. Lett. 397 2006 185 189
33. W.H. Habig, M.J. Pabst, and W.B. Jakoby Glutathione S-transferases. The first enzymatic step in mercapturic acid formation J. Biol. Chem. 249 1974 7130 7139
34. M. Hadi, I.M. Westra, V. Starokozhko, S. Dragovic, M.T. Merema, and G.M. Groothuis Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury Chem. Res. Toxicol. 26 2013 710 720
35. N.D. Halim, C.S. Weickert, B.W. McClintock, D.R. Weinberger, and B.K. Lipska Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus Neuropsychopharmacology 29 2004 1063 1069
36. F.S. Hall Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences Crit. Rev. Neurobiol. 12 1998 129 162
37. J.R. Hibbeln, and N. Salem Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy Am. J. Clin. Nutr. 62 1995 1 9
38. C. Hiemke, and S. Hartter Pharmacokinetics of selective serotonin reuptake inhibitors Pharmacol. Ther. 85 2000 1 28
39. J.A. Hinson, B. Angela, A.B. Reid, S.S. McCullough, and L.P. James Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition Drug Metab. Rev. 36 2004 805 822
40. P.J. Hissin, and R.A. Hilf A fluorometric method for the determination of oxidized and reduced glutathione in tissue Anal. Biochem. 74 1976 214 226
41. R.K. Hopper, S. Carroll, A.M. Aponte, D.T. Johnson, S. French, R.F. Shen, F.A. Witzmann, R.A. Harris, and R.S. Balaban Mitochondrial matrix phosphoproteome: effect of extra mitochondrial calcium Biochemistry 45 2006 2524 2536
42. I. Inkielewicz-Stepniak Impact of fluoxetine on liver damage in rats Pharmacol. Rep. 63 2011 441 447
43. H. Jaeschke, and H. Tadashi Role of neutrophils in acute inflammatory liver injury Liver Int. 26 2006 912 919
44. H. Jaeschke, A. Farhood, A.P. Bautista, Z. Spolarics, J.J. Spitzer, and C.W. Smith Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver Hepatology 17 1993 915 923
45. K. Jokelainen, L.A. Reinke, and A.A. Nanji NF-κB activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease Cytokine 16 2001 36 39
46. A.S. Kalgutkar, I. Gardner, R.S. Obach, C.L. Shaffer, E. Callegari, K.R. Henne, A.E. Mutlib, D.K. Dalvie, J.S. Lee, Y. Nakai, J.P. O'Donnell, J. Boer, and S.P. Harriman A comprehensive listing of bioactivation pathways of organic functional groups Curr. Drug Metab. 6 2005 161 225
47. Y. Kobayashi, M. Nishikawa, K. Hyoudou, F. Yamashita, and M. Hashida Hydrogen peroxide-mediated nuclear factor kappaB activation in both liver and tumor cells during initial stages of hepatic metastasis Cancer Sci. 99 2008 1546 1552
48. I. Kovacevic, M. Pokrajac, B. Miljkovic, D. Jovanovic, and M. Prostran Comparison of liquid chromatography with fluorescence detection to liquid chromatography-mass spectrometry for the determination of fluoxetine and norfluoxetine in human plasma. J Chromatogr. B. Anal. Technol. Biomed. Life Sci. 830 2006 372 376
49. R.K. Kuester, M.P. Waalkes, P.L. Goering, B.L. Fisher, R.S. McCuskey, and I.G. Sipes Differential hepatotoxicity induced by cadmium in Fischer 344 and Sprague-Dawley rats Toxicol. Sci. 65 2002 151 159
50. P.A. Lang, C. Contaldo, P. Georgiev, A.M. El Badry, M. Recher, M. Kurrer, L. Cervantes-Barragan, B. Ludewig, T. Calzascia, B. Bolinger, D. Merkler, B. Odermatt, M. Bader, R. Graf, P.A. Clavien, A.N. Hegazy, M. Löhning, N.L. Harris, P.S. Ohashi, H. Hengartner, R.M. Zinkernagel, and K.S. Lang Aggravation of viral hepatitis by platelet derived serotonin Nat. Med. 14 2008 756 761
51. M. Lesurtel, C. Soll, R. Graf, and P.A. Clavien Role of serotonin in the hepato-gastrointestinal tract: an old molecule for new perspectives Cell. Mol. Life Sci. 65 2008 940 952
52. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233 1994 346 357
53. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
54. Y. Lu, Q. Meng, G. Zhang, and X. Bei Clozapine-induced hepatotoxicity in rat hepatocytes by gel entrapment and monolayer culture Toxicol. In Vitro 22 2008 1754 1760
55. M.I. Lucena, A. Carvajal, R.J. Andrade, and A. Velasco Antidepressant-induced hepatotoxicity Expert Opin. Drug. Saf. 2 2003 249 262
56. J.L. Maggs, D. Williams, M. Pirmohamed, and B.K. Park The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man J. Pharmacol. Exp. Ther. 275 1995 1463 1475
57. E. Malle, G. Marsche, U. Panzenboeck, and W. Sattler Myeloperoxidase mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins Arch. Biochem. Biophys. 445 2006 245 255
58. H.Y. Meltzer The concept of atypical antipsychotic J.A. Den Boer, H.G.M. Westenberg, H.M. van Praag, Advances in the Neurobiology of Schizophrenia 1995 John Wiley & Sons England 265 273
59. H.J. Na, G. Lee, H.Y. Oh, K.S. Jeon, H.J. Kwon, K.S. Ha, H. Lee, Y.G. Kwon, and Y.M. Kim 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-kappaB activation Int. Immunopharmacol. 6 2006 1597 1608
60. Y. Nagaoka, Y. Iuchi, Y. Ikeda, and J. Fujii Glutathione reductase is expressed at high levels in pancreatic islet cells Redox Rep. 9 2004 321 324
61. A.A. Nanji, L. Miao, P. Thomas, A. Rahemtulla, S. Khwaja, S. Zhao, D. Peters, S.R. Tahan, and A.J. Dannenberg Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat Gastroenterology 112 1997 943 951
62. J.A. Navarro-Gonzálvez, C. García-Benayas, and J. Arenas Semiautomated measurement of nitrate in biological fluids Clin. Chem. 44 1998 679 681
63. 2 and cyclooxygenase-2 J. Biol. Chem. 275 2000 20136 20145
64. M.E. Ozcan, M. Gulec, E. Ozerol, R. Polat, and O. Akyol Antioxidant enzyme activities and oxidative stress in affective disorders Int. Clin. Psychopharmacol. 19 2004 89 95
65. H. Özden, K. Bildirici, D. Üstüner, C. Üstüner, B.P. Cengiz, A. Tülay, and V. YIlmaz Histopathologic examination of rat liver after experimental application of fluoxetine Türk. Patoloji Dergisi. 11 2005 9 15
66. S.B. Pajović, S. Pejić, V. Stojiljković, L. Gavrilović, S. Dronjak, and D.T. Kanazir Alterations in hippocampal antioxidant enzyme activities and sympatho-adrenomedullary system of rats in response to different stress models Physiol. Res. 55 2006 453 460
67. C.J. Parli, and J. Hicks In vivo demethylation of Lilly 110140: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine to an active metabolite Lilly 103947 Fed. Proc. 33 1974 560
68. M. Polydoro, N. Schröder, M.N. Lima, F. Caldana, D.C. Laranja, E. Bromberg, R. Roesler, J. Quevedo, J.C. Moreira, and F. Dal-Pizzol Haloperidol- and clozapine-induced oxidative stress in the rat brain Pharmacol. Biochem. Behav. 78 2004 751 756
69. T.I. Prior, P.S. Chue, P. Tibbo, and G.R. Baker Drug metabolism and atypical antipsychotics Eur. Neuropsychopharm. 9 1999 301 309
70. B.J. Sadock, and V.A. Sadock Laboratory tests in psychiatry B.J. Sadock, V.A. Sadock, Kaplan & Sadock's Concise Textbook of Clinical Psychiatry 2008 Lippincott Williams & Wilkins USA 16 21
71. M. Salter Determination of the flux control coefficient of nitric oxide synthase for nitric oxide synthesis in discrete brain regions in vivo J. Theor. Biol. 182 1996 449 452
72. G.A. Sastry Blood Chemistry-ALT and AST. Veterinary Clinical Pathology third ed. 1985 CBS Publishers Delhi
73. S. Scaccianoce, P. Del Bianco, G. Paolone, D. Caprioli, A.M. Modafferi, P. Nencini, and A. Badiani Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone Behav. Brain Res. 168 2006 323 325
74. G. Schmidt, G. Börsch, K.M. Müller, and D. Ricken Clozapine-induced cholestatic liver lesions. A case study Deut. Med. Wochenschr. 112 1987 844 846
75. M. Serra, E. Sanna, M.C. Mostallino, and G. Biggio Social isolation stress and neuroactive steroids Eur. Neuropsychopharmacol. 17 2007 1 11
76. M. Song, X. Yu, H. Zhao, T. Hang, L. Yang, and W. Xu LC-MS-MS determination and pharmacokinetic study of clozapine in human plasma Chromatographia 69 2009 1049 1054
77. M.E. Souza, A.C. Polizello, S.A. Uyemura, O. Castro-Silva, and C. Curti Effect of fluoxetine on rat liver mitochondria Biochem. Pharmacol. 48 1994 535 541
78. N. Spasojević, L.J. Gavrilovic, V. Varagic, and S. Dronjak Effects of chronic diazepam treatments on behavior on individually housed rats Arch. Biol. Sci. 59 2007 113 117
79. G.L. Squadrito, and W.A. Pryor The formation of peroxynitrite in vivo from nitric oxide and superoxide Chem. Biol. Interact. 96 1995 203 206
80. E.R. Stadtman Protein oxidation and aging Science 257 1992 1220 1224
81. R.C. Strange, P.W. Jones, and A.A. Fryer Glutathione S-transferase: genetics and role in toxicology Toxicol. Lett. 112 2000 357 363
82. T. Strekalova, R. Spanagel, O. Dolgov, and D. Bartsch Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice Behav. Pharmacol. 16 2005 171 180
83. K.D. Tew, and Z. Ronai GST function in drug and stress response Drug Resist. Updates 2 1999 143 147
84. M. Trujillo Antidepressants and the Brain 1996 California State Univ. Press USA
85. J. Uetrecht Idiosyncratic drug reactions: past, present, and future Chem. Res. Toxicol. 21 2007 84 92
86. J.L. Walgren, M.D. Mitchell, and D.C. Thompson Role of metabolism in drug-induced idiosyncratic hepatotoxicity Crit. Rev. Toxicol. 35 2005 325 361
87. Waters, 2008. Clozapine in Human Plasma on OASIS MCX by LC/MS/MS. < http://www.waters.com/webassets/cms/library/docs/720000609en.pdf > (accessed 27.02.14.).
88. D.T. Wong, F.P. Bymaster, and E.A. Engleman Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication Life Sci. 57 1995 411 441
89. D. Yajima, H. Motani, M. Hayakawa, Y. Sato, K. Sato, and H. Iwase The relationship between cell membrane damage and lipid peroxidation under the condition of hypoxia-reoxygenation: analysis of the mechanism using antioxidants and electron transport inhibitors Cell Biochem. Funct. 27 2009 338 343
90. A. Zafir, and N. Banu Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats Eur. J. Pharmacol. 572 2007 23 31
91. S. Zhou, E. Chan, W. Duan, M. Huang, and Y.Z. Chen Drug bioactivation, covalent binding to target proteins and toxicity relevance Drug Metab. Rev. 37 2005 41 213
92. J. Zlatković, and D. Filipović Stress-induced alternations in CuZnSOD and MnSOD activity in cellular compartments of rat liver Mol. Cell. Biochem. 357 2011 143 150